SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alliance Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?

To: Champolion who wrote (474)5/12/2000 10:01:00 AM
From: All Mtn Ski  Read Replies (1) | Respond to of 548
 
Excellent news!

Say goodbye to the single digits, this is exactly that ALLP needed to stabilize and push the stock higher. This is also a validation of Oxygent, after JNJ pulled out and ALLP forged ahead. I'm sure Baxter did its homework.

Go ALLP!

Tom



To: Champolion who wrote (474)5/12/2000 10:06:00 AM
From: aknahow  Read Replies (1) | Respond to of 548
 
Details not that clear. Baxter is not giving Alliance $50 million but rather will invest a total of $50 million in convertible pfd. stock. Looked at another way this has facilitated the sale of a potential total of stock by Alliance on favorable terms but it is not the same as milestone payments of $50 million, without the issuance of stock.

Apparently Alliance gets both royalties plus a share of gross profits.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News